These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 22884784)
1. Development of a stability-indicating LC method for determination of a synthetic chalcone derivative in a nanoemulsion dosage form and identification of the main photodegradation product by LC-MS. Mattos CB; Deponti VB; Barreto F; Simões CM; Andrighetti-Frohner CR; Nunes RJ; Steindel M; Teixeira HF; Koester LS J Pharm Biomed Anal; 2012 Nov; 70():652-6. PubMed ID: 22884784 [TBL] [Abstract][Full Text] [Related]
2. Fesoterodine stress degradation behavior by liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry. Sangoi MS; Todeschini V; Steppe M Talanta; 2011 May; 84(4):1068-79. PubMed ID: 21530781 [TBL] [Abstract][Full Text] [Related]
3. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities. Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517 [TBL] [Abstract][Full Text] [Related]
4. Study of forced degradation behaviour of florfenicol by LC and LC-MS and development of a validated stability-indicating assay method. Mistiri F; Louati K; Grissa O; Kallel M; Safta F Ann Pharm Fr; 2012 Nov; 70(6):333-47. PubMed ID: 23177560 [TBL] [Abstract][Full Text] [Related]
5. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms. Kumar N; Sangeetha D; Reddy SP J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461 [TBL] [Abstract][Full Text] [Related]
6. Determination of mianserin in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-ESI/MS): application to a bioequivalence study in Chinese volunteers. Xu P; Li HD; Chen BM; Ma N; Yan M; Zhu YG J Pharm Biomed Anal; 2008 Aug; 47(4-5):994-9. PubMed ID: 18514457 [TBL] [Abstract][Full Text] [Related]
7. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610 [TBL] [Abstract][Full Text] [Related]
8. LC/ESI-MS method for the determination of trimetazidine in human plasma: application to a bioequivalence study on Chinese volunteers. Jiao Y; Su M; Chen M; Jia W; Chou Y; Huang Z; Yang N; Tong W J Pharm Biomed Anal; 2007 Apr; 43(5):1804-7. PubMed ID: 17208404 [TBL] [Abstract][Full Text] [Related]
9. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant. Lalitha Devi M; Chandrasekhar KB J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800 [TBL] [Abstract][Full Text] [Related]
10. A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form. Durga Rao D; Kalyanaraman L; Sait SS; Venkata Rao P J Pharm Biomed Anal; 2010 May; 52(1):160-5. PubMed ID: 20074888 [TBL] [Abstract][Full Text] [Related]
11. Stability indicating LC method to determination of sodium montelukast in pharmaceutical dosage form and its photodegradation kinetics. Roman J; Breier AR; Steppe M J Chromatogr Sci; 2011 Aug; 49(7):540-6. PubMed ID: 21801485 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method. Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336 [TBL] [Abstract][Full Text] [Related]
13. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients. Shah RB; Bryant A; Collier J; Habib MJ; Khan MA Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511 [TBL] [Abstract][Full Text] [Related]
15. Photodegradation kinetics, cytotoxicity assay and determination by stability-indicating HPLC method of mianserin hydrochloride. Sfair LL; Graeff JS; Paim CS; Passos CS; Steppe M; Schapoval EE Pharmazie; 2012 Jun; 67(6):490-4. PubMed ID: 22822535 [TBL] [Abstract][Full Text] [Related]
16. Application of stability-indicating HPTLC method for quantitative determination of metadoxine in pharmaceutical dosage form. Kaul N; Agrawal H; Patil B; Kakad A; Dhaneshwar SR Farmaco; 2005 Apr; 60(4):351-60. PubMed ID: 15848212 [TBL] [Abstract][Full Text] [Related]
17. A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules. Mohammadi A; Haririan I; Rezanour N; Ghiasi L; Walker RB J Chromatogr A; 2006 May; 1116(1-2):153-7. PubMed ID: 16603170 [TBL] [Abstract][Full Text] [Related]
18. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR. Djabrouhou N; Guermouche MH J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a LC-MS/MS method with electrospray ionization for determination of LASSBio-579 in rat plasma. Conrado DJ; Palma EC; Fraga CA; Barreiro EJ; Rates SM; Dalla Costa T J Pharm Biomed Anal; 2007 Jan; 43(2):677-82. PubMed ID: 16979864 [TBL] [Abstract][Full Text] [Related]
20. A stability indicating LC method for zolmitriptan. Rao BM; Srinivasu MK; Sridhar G; Kumar PR; Chandrasekhar KB; Islam A J Pharm Biomed Anal; 2005 Sep; 39(3-4):503-9. PubMed ID: 15899567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]